United States · FDA National Drug Code directory

migraine relief

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0363-1235_c18857b0-45be-4d4e-8aad-b19d6d77dc98
Product NDC
0363-1235
Form
TABLET, FILM COATED
Composition / generic term
acetaminophen, aspirin, caffeine
Labeler
Walgreen Company
Marketing category
ANDA
Marketing start / end (source format)
20220616
Source listing expiry
20271231

Source-listed ingredients

  • ACETAMINOPHEN — 250 mg/1
  • ASPIRIN — 250 mg/1
  • CAFFEINE — 65 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BOTTLE in 1 CARTON (0363-1235-27) / 80 TABLET, FILM COATED in 1 BOTTLE · 0363-1235-27
  • 1 BOTTLE in 1 CARTON (0363-1235-60) / 20 TABLET, FILM COATED in 1 BOTTLE · 0363-1235-60

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →